SXL
Summit X LLC Portfolio holdings
AUM
$536M
This Quarter Return
-13.81%
1 Year Return
+15.35%
3 Year Return
+62.87%
5 Year Return
+106.58%
10 Year Return
–
AUM
$346M
AUM Growth
+$346M
(-15%)
Cap. Flow
+$3.67M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
33.79%
Holding
272
New
19
Increased
99
Reduced
106
Closed
29
Top Buys
| 1 |
Amazon
AMZN
|
$4.16M |
| 2 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
$2.01M |
| 3 |
iShares Core High Dividend ETF
HDV
|
$1.7M |
| 4 |
Enbridge
ENB
|
$1.62M |
| 5 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
$1.25M |
Top Sells
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
$1.67M |
| 2 |
iShares ESG Aware MSCI EM ETF
ESGE
|
$1.34M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
$1.13M |
| 4 |
JPMorgan US Quality Factor ETF
JQUA
|
$963K |
| 5 |
Mastercard
MA
|
$853K |
Sector Composition
| 1 | Technology | 13.16% |
| 2 | Financials | 7.7% |
| 3 | Consumer Discretionary | 7.12% |
| 4 | Healthcare | 6.48% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
226
iShares MSCI USA Value Factor ETF
VLUE
$7.1B
| $210K | 0.06% |
2,302
-12,334
| -84% | -$1.13M |
|
227
L3Harris
LHX
$51.9B
| $208K | 0.06% |
855
| – | – |
|
228
CSX Corp
CSX
$60.6B
| $205K | 0.06% |
7,022
| – | – |
|
229
Novartis
NVS
$245B
| $204K | 0.06% |
2,396
+22
| +0.9% | +$1.87K |
|
230
iShares Silver Trust
SLV
$19.6B
| $190K | 0.06% |
10,165
+1,129
| +12% | +$21.1K |
|
231
Geron
GERN
$893M
| $165K | 0.05% |
103,165
+12,000
| +13% | +$19.2K |
|
232
Snap
SNAP
$12.1B
| $143K | 0.04% |
10,810
-2,233
| -17% | -$29.5K |
|
233
Palantir
PLTR
$372B
| $117K | 0.03% |
+12,938
| New | +$117K |
|
234
Lloyds Banking Group
LYG
$64.3B
| $84K | 0.02% |
39,014
+3,487
| +10% | +$7.51K |
|
|
XXII
235
22nd Century Group
XXII
$6.15M
| $54K | 0.02% |
25,000
+2,500
| +11% | +$5.4K |
|
|
TRVN
236
DELISTED
Trevena, Inc.
TRVN
| $53K | 0.02% |
130,326
+44,506
| +52% | +$18.1K |
|
237
Lineage Cell Therapeutics
LCTX
$267M
| $48K | 0.01% |
29,925
-1,000
| -3% | -$1.6K |
|
238
Universal Safety Products, Inc.
UUU
$7.63M
| $42K | 0.01% |
+11,537
| New | +$42K |
|
|
MESO
239
Mesoblast
MESO
$1.77B
| $39K | 0.01% |
17,809
+3,000
| +20% | +$6.57K |
|
240
Denison Mines
DNN
$2.08B
| $19K | 0.01% |
19,500
-4,000
| -17% | -$3.9K |
|
241
Serina Therapeutics
SER
$54.5M
| $19K | 0.01% |
33,000
| – | – |
|
|
CYBN
242
Cybin
CYBN
$176M
| $11K | ﹤0.01% |
20,500
| – | – |
|
|
NMTR
243
DELISTED
9 Meters Biopharma, Inc. Common Stock
NMTR
| $5K | ﹤0.01% |
16,800
| – | – |
|
244
AllianceBernstein
AB
$4.38B
| – | – |
-4,320
| Closed | -$203K |
|
245
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$2.85B
| – | – |
-7,562
| Closed | -$567K |
|
246
Abbott
ABT
$231B
| – | – |
-2,118
| Closed | -$250K |
|
247
Ally Financial
ALLY
$12.6B
| – | – |
-15,190
| Closed | -$660K |
|
248
ARK Fintech Innovation ETF
ARKF
$1.34B
| – | – |
-11,254
| Closed | -$322K |
|
249
ARK Genomic Revolution ETF
ARKG
$1.04B
| – | – |
-6,953
| Closed | -$311K |
|
250
ARK Innovation ETF
ARKK
$7.45B
| – | – |
-5,053
| Closed | -$331K |
|